Lazuriton Nano Biotechnology (U.S.A.) Inc. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$0

Net Income/Loss (FY2021)

-$48.8K

Total Assets (FY2021)

$1.3K

Total Equity (FY2021)

-$368.6K

Cash Flows from Operating Activities (FY2021)

$0

Source: Lazuriton Nano Biotechnology (U.S.A.) Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.